All Posts By

CDRD

CDRD & TRIUMF Announce Collaboration to Revolutionize the Fight Against Cancer with Targeted Alpha Therapy

By CDRD, News & Events

By combining TRIUMF’s expertise in manufacturing isotopes and radiolabelling conjugates with CDRD’s ability to identify and validate potential biological targets to develop therapeutic agents such as monoclonal antibodies, new “weaponized targeted therapies” can be created for the treatment of cancers with significant unmet medical need. In doing so, the organizations are leveraging two of Canada’s complementary national strengths to create a unique global competitive advantage; while also enabling an integrated health sciences ecosystem that bridges the gap between academic research, commercialization, and patient care in targeted alpha therapeutics.

Read More

Canadian Life Sciences Leaders Come Together to Discuss and Support Recommendations within the Federal Government’s Health and Biosciences Economic Strategy Table Report

By CDRD, News & Events

To exemplify the collaborative spirit and leadership needed to advance the Canadian health and biosciences sector, Canadian life sciences leaders – CDRD, LifeSciences BC, TRIUMF Innovations and BIOTECanada – are hosting an event today to build support and encourage action and agreement that will advance recommendations from The Government of Canada’s Health and Biosciences Economic Strategy Table Report.

Read More

CDRD Appoints Didier Leconte to its Board of Directors

By CDRD, News & Events

Didier is at the forefront of life sciences investment in Canada, working with the Fonds de solidarité FTQ on a mission that is perfectly aligned with CDRD’s, to contribute to Québec’s and Canada’s economic growth by creating jobs through investments in small and medium-sized businesses, helping them scale up to be new life sciences anchor companies.

Read More